Macular hemorrhage in high myopia  

作　　者：Yunyi Liu Lian Ping Lin Lu Shida Chen 刘昀祎;练苹;吕林;陈士达(Zhongshan Ophthalmic Center,State Key Laboratory of Ophthalmology,Sun Yat-Sen University,Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science,Guangdong Provincial Clinical Research Center for Ocular Diseases,Guangzhou 510060,China)

机构地区：[1]Zhongshan Ophthalmic Center,State Key Laboratory of Ophthalmology,Sun Yat-Sen University,Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science,Guangdong Provincial Clinical Research Center for Ocular Diseases,Guangzhou 510060,China

出　　处：《Eye Science》2024年第4期401-417,共17页眼科学报(英文版)

基　　金：primarily supported by the Innovative Clinical Technique of Guangzhou(2024P-GX02);funded by the Science and Technology Program of Guangzhou,China(Grant IDs:2024A03J00515);supplemented by the Lumitin Vision to Brightness Research Funding for Young and Middle-aged Ophthalmologists(Grant ID:BCF-KH-YK-20230803-03)。

摘　　要：Macular hemorrhage(MH)is one of the most severe complications of high myopia,posing a significant threat to vision.MH can occur with or without choroidal neovascularization(CNV),with the CNV-associated form being the most prevalent.CNV-related MH may develop secondary to conditions such as pathological myopia,and punctate inner choroidopathy.Conversely,MH without CNV is often linked to factors like lacquer cracks,trauma,ocular surgery.While the exact mechanisms of CNV in high myopia are still not fully understood,anti-VEGF injections have been shown to be effective in improving visual function in patients with CNV.This review summarizes the clinical characteristics of various causes of MH and their respective treatments,providing valuable insights to help clinicians make informed diagnostic and therapeutic decisions.

关 键 词：high myopia macular hemorrhage PATHOGENESIS TREATMENT 

分 类 号：R74[医药卫生—神经病学与精神病学]